Risk factors for hospital admission among COVID-19 patients with diabetes

Abstract

‫العمر‬ ‫كان‬ ‫املنزل.‬ ‫في‬ ‫منهم‬ 52% ‫وعزل‬ ، ‫املستشفى‬ ‫إلى‬ ‫منهم‬ 48% ‫إدخال‬ ‫مت‬ ، ‫سنة‬ p=0.017(، 80 ‫؛‬ 2.56 ‫فردية]‬ ‫[نسبة‬ OR(‫سنة‬ 70-79 ‫بني‬ ‫األكبر‬ ‫مقارنة‬ ‫املستشفى‬ ‫إلى‬ ‫للدخول‬ ‫كبير‬ ‫بشكل‬ ‫عرضة‬ ‫أكثر‬)OR ‫؛84.6‬ p=0.001(9% ‫من‬ ‫أعلى‬ HbA1c ‫مستوى‬ ‫لديهم‬ ‫الذين‬ ‫املرضى‬ ، ‫وباملثل‬ ‫سنة.‬ 40< ‫ـ‬ ‫ب‬ ‫أمراض‬ ‫من‬ ‫يعانون‬ ‫الذين‬ ‫املرضى‬ ‫؛‬)OR ‫؛85.1‬ p=0.047(‫؛‬ 7%< ‫ـ‬ ‫ب‬ ‫مقارنة‬ ‫القلب‬ ‫أمراض‬ ،)OR ‫؛34.1‬ p=0.048(‫الدم‬ ‫ضغط‬ ‫ارتفاع‬ ‫مثل‬ ‫مصاحبة‬ ‫الدماغية‬ ‫الدموية‬ ‫األوعية‬ ‫أمراض‬ ،)OR ‫؛65.1‬ p=0.033(‫الدموية‬ ‫واألوعية‬ ‫كان‬ ،)OR ‫؛15.1‬ p=0.018(‫مزمن‬ ‫رئوي‬ ‫مرض‬ ،)OR ‫؛83.2‬ p=0.016(IIIa ، IIIb ،(‫املزمنة‬ ‫الكلى‬ ‫وأمراض‬ ،)OR ‫؛54.2‬ p=0.025(‫اخلبيث‬ ‫الورم‬ ‫عرضة‬ ‫أكثر‬)IV)OR ‫؛73.2‬ p=0.008(، CKD V)OR ‫؛70.5‬ p=0.007 OR(‫باألنسولني‬ ‫املعاجلني‬ ‫فإن‬ ، ‫وباملثل‬ ‫املستشفى.‬ ‫إلى‬ ‫للدخول‬ ‫ملحوظ‬ ‫بشكل‬ ‫غير‬ ‫باملرضى‬ ‫مقارنة‬ ‫املستشفى‬ ‫دخول‬ ‫لتطلب‬ ‫عرضة‬ ‫أكثر‬ ‫كانوا‬ ‫؛64.1)‬ p=0.03 ‫باألنسولني.‬ ‫املعاجلني‬ ‫تقدم‬ ‫أن‬ ‫وجد‬ ‫السكري،‬ ‫بداء‬ ‫املصابني‬ COVID-19 ‫مرضى‬ ‫بني‬ ‫اخلالصة:‬ ‫خطر‬ ‫عوامل‬ ‫أخرى‬ ‫مصاحبة‬ ‫أمراض‬ ‫ووجود‬ ،HbA1c ‫مستوى‬ ‫وارتفاع‬ ‫العمر،‬ ‫املستشفى‬ ‫لدخول‬ ‫كبيرة‬ Objectives: To elucidate the risk factors for hospital admission among COVID-19 patients with type 2 diabetes mellitus (T2DM).

COVID-19 Community Transmission among Healthcare Workers at a Tertiary Care Cardiac Center

“…Patients who presented with any of the following features were admitted to the hospital: a respiratory rate of 30/min or more; blood oxygen saturation of 93% or less; partial pressure of oxygen/fraction of inspired oxygen ratio below 300; lung infiltrates above 50% of the lung field; acute respiratory distress syndrome, sepsis, altered consciousness, multi-organ failure, or cytokine release syndrome [ 16 ].…”

COVID-19 among people with diabetes mellitus in Saudi Arabia: Current situation and new perspectives

“… Retrospective study King Abdullah Hospital in Bisha Province, Saudi Arabia 27 % (37/137) Abohamr et al, 2020 [ 36 ] March 23, 2020 to15 th June 2020 A record-based case-series study King Saud Medical City, Riyadh, Saudi Arabia. 46.4 % (356/768) Al-Omari et al, 2020 [ 38 ] April 22, 2020 to May 21, 2020 Descriptive, cross-sectional study non-intensive care unit only) Dr. Sulaiman Al-Habib Medical Group's hospitals, As-Suwaidi, Rayan, Al-Takhassusi, Olaya and Al-Hammadi hospital, Riyadh, Saudi Arabia 10 % (41/401) Al Hayek et al, 2020b [ 6 ] May 2020 to July 2020 Retrospective study Prince Sultan Military Medical City, Riyadh, Saudi Arabia 12.6 % (920/7260) Alguwaihes et al, 2020 [ 27 ] May 2020 to July 2020 Retrospective study King Saud University Medical City -King Khaled University Hospital, Riyadh, Saudi Arabia 68.3 % (300/439) Sheshah et al, 2021 [ 43 ] May 1, 2020 to July 31, 2020 Retrospective study King Salman Hospital, Riyadh, Saudi Arabia. 45.7 % (137/300) Ghoraba et al, 2021 [ 39 ] 15th March to June 30, 2020.…”

“…Later, at Prince Sultan Military Medical City, Riyadh, a large, retrospective, three-month study was done on a total of 7260 COVID-19 patients from May 2020 to July 2020. The results reported 920 (12.6 % including patients isolated at home) as having T2D [ 6 ]. Further, it was clear that the older individuals with diabetes, and those showing higher HbA1c levels, as well as patients with comorbidities like hypertension, cardiovascular disease, cerebrovascular disease, chronic pulmonary disease, chronic kidney disease, malignancy, and those requiring insulin treatments, had a greater likelihood of requiring hospitalization [ 6 ].…”

“…The results reported 920 (12.6 % including patients isolated at home) as having T2D [ 6 ]. Further, it was clear that the older individuals with diabetes, and those showing higher HbA1c levels, as well as patients with comorbidities like hypertension, cardiovascular disease, cerebrovascular disease, chronic pulmonary disease, chronic kidney disease, malignancy, and those requiring insulin treatments, had a greater likelihood of requiring hospitalization [ 6 ]. At King Saud University Medical City and King Khaled University Hospital, Riyadh, Saudi Arabia, a retrospective study performed on 439 patients showed the DM prevalence was 68.3 %, a result drawn from available records and newly diagnosed cases.…”

“…It is evident that COVID-19 and diabetes mellitus (DM) significantly impact global health worldwide, including Saudi Arabia [ 4 , 5 ]. From the initial period of the COVID-19 pandemic, patients with diabetes have been documented as having a higher susceptibility to the infection and carrying a higher mortality risk from this disease [ 6 , 7 ]. Furthermore, in previous infectious disease epidemics (SARS and MERS), a high glucose concentration was shown to be an independent predictor of mortality and morbidity; this is also likely to be the case for COVID-19 [ 8 , 9 ].…”